potential 75%+ return, $CMPS
Updated
Compass Pathways deals with psychedelics and their promising properties when it comes to the treatment of mental illnesses.
Purple Zone: Safe Entry
Green Zone: Risk Entry
76% potential return.
Citron Research has a $100 PT.
Citigroup has a $67 PT.
Bullish MACD cross
Consolidating for the past 113 days
Purple Zone: Safe Entry
Green Zone: Risk Entry
76% potential return.
Citron Research has a $100 PT.
Citigroup has a $67 PT.
Bullish MACD cross
Consolidating for the past 113 days
Trade active
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.